NASHVILLE, Tenn. (AP) -- Tim McGraw will be saluting veterans in a big way while on tour this summer. The country music superstar is giving away 25 mortgage-free houses - one for each stop on his upcoming "Brothers of the Sun" tour with Kenny Chesney - to wounded or needy service members. McGraw will kick off the campaign with a Memorial Day concert for military members at New York City's Beacon Theatre during Fleet Week. "My sister's a veteran, my uncle's a veteran, my grandfather was a veteran, one of my best friends is a veteran," McGraw said in an interview. "I've known people my whole life who are in service to America. And I think in my position to be able to do something ... Continue reading →

View readers' comments and opinions from the CBS News community on the topic: Continue reading →

Tweet Abstract TypesCRAClinical Review AbstractLBALate-Breaking AbstractTPSTrials in Progress AbstracteAbstracts selected for publication but not presentation at the Annual Meeting^Abstracts granted an exception in accordance with ASCO's Conflict of Interest Policy Attend this session at theASCO Annual Meeting!Session: Health Services ResearchType: General Poster SessionTime: Monday June 4, 1:15 PM to 5:15 PMLocation: S Hall A2Author(s): Winston Wong, Joseph Cooper, Steve Richardson, Bruce A. Feinberg; CareFirst BlueCross BlueShield, Baltimore, MD; Cardinal Health, Specialty Solutions, Dublin, OH; Genomic Health, Redwood City, CAAbstract DisclosuresAbstract: Background: CareFirst BlueCross BlueShield (CFBCBS) insurance network partnered with Cardinal Health Specialty Solutions (CHSS) to develop a cancer care pathway for network physicians in 2008. The program included a recommendation for molecular diagnostic testing with the Oncotype DX assay for pts with early-stage estrogen receptor-positive ... Continue reading →

Tweet Abstract TypesCRAClinical Review AbstractLBALate-Breaking AbstractTPSTrials in Progress AbstracteAbstracts selected for publication but not presentation at the Annual Meeting^Abstracts granted an exception in accordance with ASCO's Conflict of Interest Policy Attend this session at theASCO Annual Meeting!Session: Health Services ResearchType: General Poster SessionTime: Monday June 4, 1:15 PM to 5:15 PMLocation: S Hall A2Author(s): Francisco Emilio Vera Badillo, Roman Shapiro, Alberto Ocana, Eitan Amir, Ian Tannock; Princess Margaret Hospital, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada; Princess Margaret Hospital and University of Toronto, Toronto, ON, CanadaAbstract DisclosuresAbstract: Background: Phase III RCTs are designed to assess clinically important differences in endpoints that reflect benefit to patients. Accurate and unbiased reporting is essential to guide ... Continue reading →

Tweet Abstract TypesCRAClinical Review AbstractLBALate-Breaking AbstractTPSTrials in Progress AbstracteAbstracts selected for publication but not presentation at the Annual Meeting^Abstracts granted an exception in accordance with ASCO's Conflict of Interest Policy Attend this session at theASCO Annual Meeting!Session: Health Services ResearchType: Poster Discussion SessionTime: Tuesday June 5, 8:00 AM to 12:00 PMLocation: S405Discussion Time: Tuesday June 5, 11:30 AM to 12:30 PMLocation: S406Author(s): Trevor Joseph Royce, Jonathan Todd, William A. Stokes, Ian M. Allen, Ronald C. Chen; UNC-CH School of Medicine, Chapel Hill, NC; Department of Epidemiology, UNC-CH Gillings School of Global Public Health, Chapel Hill, NC; University of North Carolina at Chapel Hill, Chapel Hill, NCAbstract DisclosuresAbstract: Background: Prostate-specific antigen (PSA) screening increases the diagnosis of low-risk and potentially clinically insignificant CaP, which raises concern ... Continue reading →

Criticism that the FDA is too slow on drug approvals is a perennial theme for the pharmaceutical industry, which spends more than $50 billion annually to develop new drugs. The complaint has resurfaced in the past year as the industry renegotiates the fees it must pay the FDA to review new drug applications — a program which is reauthorized by Congress every five years.The study authors address this issue directly, defending the agency’s performance. “Our findings contradict recent criticisms of the speed of review by the FDA and lead to questions about whether the speed of the review process is justified as an emphasis ... particularly since the FDA continues to outpace its European and Canadian peers,” the authors state.The median time for drug reviews ... Continue reading →

It’s startling stuff. But will the experimental brain-controlled technology ever help paralyzed people in everyday life?Experts in the technology and in rehabilitation medicine say they are optimistic that it will, once technology improves and the cost comes down.The latest report, which was published online Wednesday in the journal Nature, comes from scientists at Brown University, the Providence VA Medical Center in Rhode Island, Harvard Medical School and elsewhere.It describes how two people who lost use of their arms and legs because of strokes years before were able to control free-standing robotic arms with the help of a tiny sensor implanted in their brains.The sensor, about the size of a baby aspirin, eavesdropped on the electrical activity of a few dozen brain cells as the study ... Continue reading →